Found: 26
Select item for more details and to access through your institution.
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12450, doi. 10.3390/ijms232012450
- By:
- Publication type:
- Article
Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 9, p. 3399, doi. 10.3390/ijms21093399
- By:
- Publication type:
- Article
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 5227, doi. 10.1007/s10238-023-01205-y
- By:
- Publication type:
- Article
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1208741
- By:
- Publication type:
- Article
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45000-z
- By:
- Publication type:
- Article
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 9, p. 1271, doi. 10.1007/s00277-013-1757-6
- By:
- Publication type:
- Article
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2929, doi. 10.3390/cancers16172929
- By:
- Publication type:
- Article
P-036: Implementation of IgH/k Next Generation Sequencing for Multiple Myeloma Minimal Residual Disease monitoring: advantages in patients' management during daily clinical practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S58, doi. 10.1016/S2152-2650(21)02170-4
- By:
- Publication type:
- Article
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S35, doi. 10.1016/S2152-2650(21)02129-7
- By:
- Publication type:
- Article
P-053: BoBafit: a Copy Number-clustering tool to refit and recalibrate the diploid region of Multiple Myeloma genomic profiles.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S67, doi. 10.1016/S2152-2650(21)02187-X
- By:
- Publication type:
- Article
OAB-059: Towards a comprehensive multimodal minimal residual disease assessment in multiple myeloma: the role of circulating cell-free DNA to define the extent of disease spreading.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S37, doi. 10.1016/S2152-2650(21)02131-5
- By:
- Publication type:
- Article
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S4, doi. 10.1016/S2152-2650(21)02080-2
- By:
- Publication type:
- Article
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis", caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e78, doi. 10.1016/j.clml.2019.09.125
- By:
- Publication type:
- Article
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e72, doi. 10.1016/j.clml.2019.09.115
- By:
- Publication type:
- Article
A Maturation Index defines Newly Diagnosed Multiple Myeloma Patients with advanced immunophenotypic and Molecular Differentiation profiles associated with poor prognosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e69, doi. 10.1016/j.clml.2019.09.110
- By:
- Publication type:
- Article
Analysis of the genomic and transcriptomic landscape of chemoresistant multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e58, doi. 10.1016/j.clml.2019.09.091
- By:
- Publication type:
- Article
Evolutionary Fitness of Relapsed Multiple Myeloma Patients Who Responded to Upfront Combination Therapy Including New Drugs.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e12, doi. 10.1016/j.clml.2017.03.020
- By:
- Publication type:
- Article
A More Mature Immunophenotypic Make-up of Multiple Myeloma Clone(s) at Diagnosis Correlates With a Higher Genomic Instability.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e11, doi. 10.1016/j.clml.2017.03.019
- By:
- Publication type:
- Article
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 57, doi. 10.1002/hon.2932
- By:
- Publication type:
- Article
A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 41, doi. 10.1002/hon.2820
- By:
- Publication type:
- Article
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. 1085, doi. 10.1002/ajh.23835
- By:
- Publication type:
- Article
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 8, p. 657, doi. 10.3390/cells13080657
- By:
- Publication type:
- Article
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1001048
- By:
- Publication type:
- Article
Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00189
- By:
- Publication type:
- Article
Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00699
- By:
- Publication type:
- Article